ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Sai Life Sciences Limited has announced the allotment of equity shares under its ESOP scheme. This allotment increases the company's paid-up share capital.
Sai Life Sciences allotted 24,000 shares upon exercise of ESOP 2008 options at ₹188.90 per share. This issuance increases the company's paid-up equity share capital.
Sai Life Sciences Limited allotted 80,600 equity shares under its ESOP/ESPS scheme. This increased the company's total paid-up share capital to ₹21.24 Crore.
Sai Life Sciences Limited allotted 80,600 equity shares following the exercise of options under its 2008 and 2018 ESOP plans. The total paid-up capital increased to ₹21.24 Crore.
Sai Life Sciences Limited allotted 18,700 equity shares under its ESOP/ESPS scheme. This issuance increases the total paid-up share capital of the company.
Sai Life Sciences allotted 18,700 equity shares under its Employee Stock Option Plan 2008. The exercise of these options realized Rs. 0.35 Crore for the company.
Sai Life Sciences allotted 8,900 equity shares under its ESOP/ESPS scheme. This increases the total paid-up share capital to 21,22,94,916 shares.
Sai Life Sciences Limited allotted 8,900 equity shares under its ESOP 2008 scheme. The company realized Rs 0.17 Crore from the exercise of these options.
Sai Life Sciences Limited allotted 2,44,281 equity shares upon the exercise of options under its ESOP 2008 and MESOP 2018 plans. The company realized ₹3.38 Crore from this exercise. Following this allotment, the total issued share capital increased to 21,20,23,515 equity shares.